TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects

This publication has 26 references indexed in Scilit:

• Implementation of TPMT testing
  British Journal of Clinical Pharmacology, 2014
• Randomised clinical trial: individualised vs. weight‐based dosing of azathioprine in Crohn's disease
  Alimentary Pharmacology & Therapeutics, 2013
• ITPA (inosine triphosphate pyrophosphatase): From surveillance of nucleotide pools to human disease and pharmacogenetics
  Mutation Research - Reviews in Mutation Research, 2013
• Nomenclature for alleles of the thiopurine methyltransferase gene
  Pharmacogenetics and Genomics, 2013
• A New Thiopurine S‐Methyltransferase Haplotype Associated With Intolerance to Azathioprine
  The Journal of Clinical Pharmacology, 2013
• Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
  Journal of Crohn's and Colitis, 2012
• Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease
  Alimentary Pharmacology & Therapeutics, 2011
• Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy
  British Journal of Clinical Pharmacology, 2010
• The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
  Journal of Crohn's and Colitis, 2010
• Genetic Polymorphism of Inosine Triphosphate Pyrophosphatase Is a Determinant of Mercaptopurine Metabolism and Toxicity During Treatment for Acute Lymphoblastic Leukemia
  Clinical Pharmacology & Therapeutics, 2008